tert-Butyl (7-aminoheptyl)carbamate

Catalog No. :
ACJLAO385
CAS No. :
99733-18-3
Molecular Formula :
C12H26N2O2
Molecular Weight :
230.35

IUPAC Name:tert-butyl (7-aminoheptyl)carbamate

tert-Butyl (7-aminoheptyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$146.00Login to see priceIn stockIn stock
5g97%$449.00Login to see priceIn stockIn stock
25g97%$2160.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (7-aminoheptyl)carbamate
IUPAC Nametert-butyl (7-aminoheptyl)carbamate
MDL No.MFCD02094498
Molecular FormulaC12H26N2O2
Molecular Weight230.35
SMILESO=C(OC(C)(C)C)NCCCCCCCN
InChI KeyDTJYPERGUPPXRU-UHFFFAOYSA-N
SynonymN-(tert-butoxycarbonyl)-1,7-heptanediamine;Heptane-1,7-diamine, N-Boc protected;1-BOC-1,7-DIAMINOHEPTANE;TERT-BUTYL 7-AMINOHEPTYLCARBAMATE;1,7-Diaminoheptane, N1-BOC protected;1,7-Diaminoheptane, N1-BOC protected 95%;tert-Butyl 7-aminoheptylcarbamate 1-Boc-1,7-diaminoheptane 1,7-Diaminoheptane N1-boc protected;N1-BOC-1,7-DIAMINOHEPTANE
CAS No.99733-18-3
PubChem CID4328520

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACJLAO385 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFNDC147 route compound structure diagram
    ACFNDC147646-19-5 In Stock
  4. Then
  5. ACJLAO385 route product structure diagram
    ACJLAO38599733-18-3 In Stock
Inquiry

2. ACJLAO385 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJLAO385 route product structure diagram
    ACJLAO38599733-18-3 In Stock
Inquiry

Comments (0)